Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients who fit the inclusion criteria are admitted into the study. They are given 3 IV injection of MBL in the first week and one tablet three times a day for 16 weeks.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Mecobalamin | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Mattis dementia rating scale |
| Measure | Description | Time Frame |
|---|---|---|
| Category fluency test | ||
| Delirium rating scale | ||
| CNPI |
Not provided
Inclusion:
Exclusion:
Significant communication problems
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Romeo Chu | Eisai Asia Regional Services Ltd. | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chinese University of Hong Kong | Hong Kong | Hong Kong | China |
Not provided
| ID | Term |
|---|---|
| C019476 | mecobalamin |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| MMSE |
| Plasma homocysteine |
| Plasma isoprostane |